Test Code IMML52 hCG, Quant (Tumor Marker)
Clinical Information
This test is not useful as a cancer screening test. Serum markers are not specific for malignancy and values may vary by method. Values obtained with different assay methods cannot be used interchangeably. Normal serum levels of hCG do not always exclude tumor persistence since tumors may undergo transition to differentiated teratomas, which may not produce hCG. Transient elevations of serum hCG can occur following chemotherapy in patients with susceptible tumors, due to massive tumor cell lysis; these transient elevations should not be confused with tumor progression. For assays employing antibodies, the possibility exists for interference by human anti-animal antibodies (i.e., heterophile antibodies) in the patient sample. Patients who have been regularly exposed to animals or have received immunotherapy or diagnostic procedures utilizing immunoglobulins or immunoglobulin fragments may produce antibodies, (eg, HAMA), that interfere with immunoassays. This may falsely elevate or falsely decrease the results.
Synonym
- HCGTM
Specimen Required
Preferred Container/Tube: Gold SST Top
Acceptable Container/Tube: Gold SST Top
Specimen Volume: 3 mL
Specimen Minimum Volume: 1 mL
Specimen Stability Information
Ambient: 8 hours
Refrigerated: 5 days
Rejected Due To
- Gross hemolysis
- Gross icterus
- Quantity not sufficient
- Quality not acceptable
Reference Values
<10.0 mIU/mL
Method Description
Two-site sandwich immunoassay chemiluminescent.
Performing Lab
Clinical Lab UH
Clinical Lab University East
Clinical Lab James
Clinical Lab West Campus
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 day
Reporting Name
hCG, Quant (Tumor Marker)
CPT Code Information
84702
LOINC Code Information
19080-1